サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1565074

フーバー針の世界市場

Huber Needles

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
フーバー針の世界市場
出版日: 2024年10月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

フーバー針の世界市場は2030年までに9,430万米ドルに達する見込み

2023年に6,780万米ドルと推定されるフーバー針の世界市場は、分析期間2023-2030年にCAGR 4.8%で成長し、2030年には9,430万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである点滴がん治療アプリケーションは、CAGR 5.4%を記録し、分析期間終了時には4,570万米ドルに達すると予測されます。輸血アプリケーション分野の成長率は、分析期間中CAGR 4.3%と推定されます。

米国市場は1,840万米ドルと推定、中国はCAGR4.5％で成長予測

米国のフーバー針市場は、2023年に1,840万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2023-2030年のCAGRを4.5%として、2030年までに1,480万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.7％と3.7％と予測されています。欧州では、ドイツがCAGR 3.9%で成長すると予測されています。

世界のフーバー針市場- 主要動向と促進要因のまとめ

フーバー針は安全で効率的な長期投薬の鍵か？

フーバー針は、現代のヘルスケアにおいて欠かすことのできないツールとなっていますが、なぜ安全で効率的な長期投薬に不可欠なのでしょうか。フーバー針は、長期間の静脈内治療が必要な患者に使用されるポートなど、植え込まれたバスキュラーアクセスデバイスにアクセスするために設計された、コアリングのない特殊な針です。これらの針は、化学療法、輸血、長期の静脈内治療を受ける患者に広く使用されており、静脈を繰り返し穿刺することなく、信頼性が高く安全な方法で薬剤を投与することができます。

フーバー針の魅力は、組織の損傷を最小限に抑え、コアリング（組織の小片が切断され、血流に導入されること）のリスクを軽減するユニークなデザインにあります。そのため、中心静脈ポートに頻繁に、または長期間アクセスする必要がある患者に最適です。フーバー針は、快適性と安全性の両方を提供し、不必要な痛みや合併症を引き起こすことなく、治療を効果的に行うことを保証します。ヘルスケアプロバイダーが、慢性的な治療環境における患者ケアの向上を目指す中で、フーバー針は、不快感やリスクを最小限に抑えながら、バスキュラーアクセスデバイスの完全性を維持するために不可欠です。

技術はどのようにフーバー針を進歩させたか？

技術の進歩により、フーバー針の安全性、機能性、使いやすさが大幅に改善され、長期間の薬物送達において、より効率的で信頼性の高いものとなりました。最も重要な進歩の一つは、安全設計されたフーバー針のイントロダクションです。これらの注射針には、医療従事者を偶発的な針刺し事故から守る安全機構が装備されており、血液媒介病原体にさらされる可能性があります。多くのフーバー針では、針の自動引き込みやシールドなどの安全機能が標準装備され、傷害のリスクを軽減し、臨床現場でのより安全な作業環境を促進しています。

素材やコーティングの改良により、フーバー針の性能も向上しています。最新のフーバー針は、耐久性、柔軟性、生体適合性を提供する高度なステンレス鋼で作られていることが多いです。一部の針には、挿入時の摩擦を軽減するコーティングが施され、患者さんにとってよりスムーズで快適なプロセスを実現しています。このようなコーティングは、周囲組織への外傷を最小限に抑え、ポート部位の刺激や感染の可能性を軽減するのにも役立ちます。

安全性と素材の改良に加え、フーバー針のデザインもより洗練され、精度と患者の快適性を高める工夫がなされています。多くの新型モデルは、医療従事者が扱いやすく、正確な位置決めができるよう、角度をつけたり、人間工学に基づいたデザインになっています。これにより、挿入時の合併症が少なくなり、患者のポートへのアクセスがより安定します。さらに、人間工学に基づいたデザインは、複雑で高圧な環境でこれらの針を扱わなければならないことが多い看護師や医師にとって、全体的な使い勝手を向上させます。

フローコントロールフーバー針は、もう一つの重要な進歩です。これらの鍼は、鍼を通る薬液の流れを改善し、投与量をより効率的に確保するように設計されています。化学療法や輸血の場合、正確で安定した流量を確保することは、治療の有効性と患者の安全性の両方にとって極めて重要です。流量制御されたフーバー針は、閉塞や一貫性のない送達の可能性を低減し、患者ケアを損なう可能性があります。

より細いゲージのフーバー針が利用できるようになったことで、フーバー針の用途も広がりました。細い鍼は、挿入時の痛みや組織へのダメージが少なく、特に頻繁な治療が必要な患者にとって快適です。これらの細い針は、効果的なポートアクセスを維持しながら不快感を最小限に抑えるため、小児患者や皮膚や組織が敏感な患者にとって特に有益です。

なぜフーバー針は長期的な患者ケアと薬物送達に不可欠なのでしょうか？

フーバー針は、頻繁な点滴治療を必要とする患者に、安全で信頼性が高く、侵襲性の低い方法で血管ポートにアクセスすることができるため、長期的な患者ケアと薬物送達に不可欠です。化学療法、慢性疼痛管理、長期の点滴治療を受けている患者の多くは、医療従事者が血流に直接治療を投与できる埋め込み型ポートの恩恵を受けています。フーバー針は、これらのポートを傷つけることなくアクセスできるよう特別に設計されており、ポートの機能を長期間維持することができます。

フーバー針の主な利点の一つは、穴を開けないデザインです。フーバー針が血管ポートを穿刺する際、組織を切除しないため、コアリングや血流汚染のリスクを軽減することができます。この機能は、ポートの完全性を維持し、感染や閉塞などの合併症を予防するために不可欠です。救命治療をポートに頼る患者にとって、ポートの寿命と安全性を確保することは非常に重要であり、フーバー針はこのプロセスにおいて重要な役割を果たしています。

フーバー針はまた、繰り返し針を刺すことに伴う痛みや外傷を軽減することで、患者の快適性を向上させます。従来の針は、ポートに何度もアクセスするために使用されると、大きな不快感や組織損傷を引き起こします。しかし、フーバー針のデザインは、組織外傷を最小限に抑え、長期治療レジメンに好ましい選択肢となります。これは、数ヶ月から数年にわたり、毎週、あるいは毎日ポートにアクセスする必要がある化学療法患者にとって、特に重要なことです。フーバー針を使用することで、痛みを最小限に抑え、感染のリスクを軽減し、患者の全体的な健康を増進することができます。

フーバー針が重要なもう一つの理由は、安全でコントロールされた薬物送達です。化学療法など、正確な投与とタイミングが不可欠な治療において、フーバー針は、合併症を起こすことなく、薬剤が血流に直接投与されることを保証します。その信頼性は、薬剤の漏れや閉塞など、治療効果を損なう危険性を減らす上で非常に重要です。さらに、幅広い点滴療法や点滴速度に適合するため、化学療法から非経口栄養まで、様々な臨床用途に使用することができます。

フーバー針は、ヘルスケア従事者の保護にも不可欠です。フーバー針は、安全設計された機能を統合することで、HIVや肝炎などの血液感染症を媒介する偶発的な針刺し事故の防止に役立ちます。医療従事者が毎日何本もの針を扱うような忙しい臨床環境では、フーバー針の安全機能は、スタッフを危険にさらすことなく治療が行われることを保証し、追加の保護レイヤーを提供します。

フーバー針市場の成長を促進する要因は？

フーバー針市場の成長には、慢性疾患の有病率の上昇、化学療法やその他の長期治療に対する需要の増加、針安全技術の進歩など、いくつかの要因があります。主な促進要因の1つは、長期的な静脈内治療を必要とする患者数の増加、特にがん治療を受けている患者の増加です。世界のがん罹患率の上昇に伴い、化学療法を受ける患者が増加しており、多くの場合、ポートのようなバスキュラーアクセスデバイスを使用しています。これらの器具への安全で信頼性の高いアクセスの必要性が、非穿孔で快適かつ効果的なポートアクセス用ソリューションを提供するフーバー針の需要増加に寄与しています。

さまざまな慢性疾患に対する移植ポートの使用が拡大していることも、市場の成長を後押しする重要な要因です。ポートは腫瘍だけでなく、自己免疫疾患、慢性疼痛、非経口栄養による長期栄養補給が必要な患者にも使用されています。このような治療が一般的になるにつれ、合併症を引き起こすことなく安全にポートにアクセスできるフーバー針に対する需要は高まり続けると思われます。

針の安全技術の進歩も市場拡大の原動力となっています。針刺し損傷とそれに関連する健康リスクに対する認識が高まるにつれ、安全設計されたフーバー針の開発と採用が重視されるようになっています。これらの針は、血液媒介病原体への偶発的な曝露のリスクを低減し、ヘルスケア従事者と患者の両方を保護します。ヘルスケア現場における労働安全性の向上に重点を置くことで、安全針が広く採用されるようになり、フーバー針市場全体の成長に寄与しています。

高齢化も市場成長の大きな要因です。世界人口の高齢化に伴い、がん、心血管疾患、糖尿病などの慢性疾患を抱える患者の数が増加しています。これらの患者の多くは、長期の点滴治療や定期的な血管ポートへのアクセスを必要とし、フーバー針の需要を牽引しています。さらに、高齢の患者は静脈がよりデリケートであるため、フーバー針は組織の損傷を最小限に抑え、治療中の快適性を確保するための好ましい選択肢となっています。

フーバー針に使用されているデザインや素材における技術的進歩も、市場の成長に寄与しています。フーバー針の精度、快適性、安全性を高める技術革新により、ヘルスケアプロバイダーにとってフーバー針はより魅力的なものとなっています。より細い針、人間工学に基づいたデザイン、高度な安全機能の開発により、患者とヘルスケア従事者の双方にとって使い勝手が向上しました。このような技術革新が進むにつれて、フーバー針の市場はさらに拡大すると予想され、ヘルスケアプロバイダーは長期的で質の高いケアを提供するための最良のツールを求めています。

患者中心のケアへの注目が高まっていることも、フーバー針市場の成長に影響を与えている要因です。ヘルスケアプロバイダーが長期治療を受ける患者の生活の質を向上させることに重きを置くようになり、不快感や合併症を最小限に抑える医療機器への需要が高まっています。フーバー針は、痛みの軽減と血管ポートの保護に重点を置いたデザインで、これらの目標に合致しており、患者ケア戦略において重要な要素となっています。

慢性疾患の増加、安全技術の進歩、長期的な治療ソリューションへのニーズの高まりにより、フーバー針市場は継続的な成長が見込まれています。ヘルスケアプロバイダーが安全性、効率性、患者の快適性を優先する中、フーバー針は、様々な医療分野にわたる重要な治療を安全かつ効果的に提供するために不可欠なツールであり続けるでしょう。

調査対象企業の例（全41件）

  • AngioDynamics, Inc.
  • B. Braun Medical, Inc.
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • EXELINT International Co.
  • Nipro Medical Corporation
  • Smiths Medical
  • Thibaut SAS
  • Vygon SA

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP12448

Global Huber Needles Market to Reach US$94.3 Million by 2030

The global market for Huber Needles estimated at US$67.8 Million in the year 2023, is expected to reach US$94.3 Million by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. IV Cancer Treatment Application, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$45.7 Million by the end of the analysis period. Growth in the Blood Transfusions Application segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$18.4 Million While China is Forecast to Grow at 4.5% CAGR

The Huber Needles market in the U.S. is estimated at US$18.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$14.8 Million by the year 2030 trailing a CAGR of 4.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.7% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Huber Needles Market - Key Trends and Drivers Summarized

Are Huber Needles the Key to Safe and Efficient Long-Term Medication Delivery?

Huber needles have become an indispensable tool in modern healthcare, but why are they so essential for the safe and efficient delivery of medications over extended periods? A Huber needle is a specialized, non-coring needle designed to access implanted vascular access devices, such as ports used in patients requiring long-term intravenous (IV) treatments. These needles are widely used in patients undergoing chemotherapy, blood transfusions, or long-term IV therapy, as they provide a reliable and safe way to administer medication without repeatedly puncturing veins.

The appeal of Huber needles lies in their unique design, which minimizes tissue damage and reduces the risk of coring (where a small piece of tissue is cut and introduced into the bloodstream). This makes them ideal for patients who need frequent or long-term access to central venous ports. Huber needles offer both comfort and safety, ensuring that treatments are delivered effectively without causing unnecessary pain or complications. As healthcare providers seek to enhance patient care in chronic treatment settings, Huber needles are critical for maintaining the integrity of vascular access devices while minimizing discomfort and risk.

How Has Technology Advanced Huber Needles?

Technological advancements have significantly improved the safety, functionality, and ease of use of Huber needles, making them more efficient and reliable for long-term medication delivery. One of the most important developments is the introduction of safety-engineered Huber needles. These needles are equipped with safety mechanisms that protect healthcare workers from accidental needlestick injuries, which can expose them to bloodborne pathogens. Safety features like automatic needle retraction or shielding have become standard in many Huber needles, reducing the risk of injury and promoting a safer work environment in clinical settings.

Improved materials and coatings have also enhanced the performance of Huber needles. Modern Huber needles are often made with advanced stainless steel, which provides durability, flexibility, and biocompatibility. Some needles feature coatings that reduce friction during insertion, making the process smoother and more comfortable for patients. These coatings can also help minimize trauma to the surrounding tissue, reducing irritation and the potential for infection around the port site.

In addition to safety and material improvements, the design of Huber needles has become more refined, with innovations that enhance precision and patient comfort. Many newer models have angled or ergonomic designs that make them easier for healthcare providers to handle and position accurately. This leads to fewer complications during insertion and more consistent access to the patient’s port. Additionally, the ergonomic design improves the overall user experience for nurses and doctors, who must often handle these needles in complex, high-pressure environments.

Flow-controlled Huber needles represent another significant advancement. These needles are designed to improve the flow of medication or fluids through the needle, ensuring that dosages are administered more efficiently. In the context of chemotherapy or blood transfusions, ensuring accurate and steady flow rates is crucial for both the efficacy of treatment and patient safety. Flow-controlled Huber needles help reduce the likelihood of blockages or inconsistent delivery, which can compromise patient care.

The availability of smaller gauge Huber needles has also expanded the applications of these devices. Smaller gauge needles cause less pain and tissue damage upon insertion, making them more comfortable for patients, especially those requiring frequent treatments. These finer needles are particularly beneficial for pediatric patients or individuals with more sensitive skin or tissue, as they minimize discomfort while maintaining effective port access.

Why Are Huber Needles Critical for Long-Term Patient Care and Medication Delivery?

Huber needles are critical for long-term patient care and medication delivery because they provide a safe, reliable, and less invasive method for accessing vascular ports in patients who require frequent IV treatments. Many patients undergoing chemotherapy, chronic pain management, or long-term IV therapy benefit from implanted ports, which allow healthcare providers to administer treatments directly into the bloodstream. Huber needles are specially designed to access these ports without damaging them, ensuring that the port remains functional over extended periods.

One of the primary advantages of Huber needles is their non-coring design. When a Huber needle punctures a vascular port, it does not remove tissue, thereby reducing the risk of coring and contamination of the bloodstream. This feature is essential for maintaining the integrity of the port and preventing complications such as infections or blockages. For patients who depend on their ports for life-saving treatments, ensuring the longevity and safety of the port is crucial, and Huber needles play a vital role in this process.

Huber needles also improve patient comfort by reducing the pain and trauma associated with repeated needle insertions. Traditional needles can cause significant discomfort and tissue damage when used to access a port multiple times. However, the design of Huber needles minimizes tissue trauma, making them a preferred option for long-term treatment regimens. This is especially important in chemotherapy patients, who may need weekly or even daily access to their ports over the course of several months or years. The use of Huber needles helps minimize pain, reduces the risk of infection, and promotes better overall patient well-being.

The safe and controlled delivery of medications is another reason why Huber needles are so important. In treatments such as chemotherapy, where precise dosing and timing are essential, Huber needles ensure that the medication is delivered directly into the bloodstream without complications. Their reliability is critical in reducing the risk of drug leaks, blockages, or other issues that could compromise the efficacy of treatment. Additionally, their compatibility with a wide range of IV therapies and infusion rates makes them versatile for various clinical applications, from chemotherapy to parenteral nutrition.

Huber needles are also vital for the protection of healthcare workers. With the integration of safety-engineered features, Huber needles help prevent accidental needlestick injuries, which can transmit bloodborne diseases such as HIV or hepatitis. In busy clinical environments where healthcare workers may handle multiple needles daily, the safety features of Huber needles provide an added layer of protection, ensuring that treatments are administered without putting staff at risk.

What Factors Are Driving the Growth of the Huber Needles Market?

Several factors are driving the growth of the Huber needles market, including the rising prevalence of chronic diseases, increasing demand for chemotherapy and other long-term treatments, and advancements in needle safety technology. One of the primary drivers is the growing number of patients requiring long-term intravenous therapies, particularly those undergoing cancer treatment. As the global incidence of cancer rises, more patients are being treated with chemotherapy, often through vascular access devices like ports. The need for safe and reliable access to these devices is contributing to the increased demand for Huber needles, which offer a non-coring, comfortable, and effective solution for port access.

The expanding use of implanted ports for a variety of chronic conditions is another key factor fueling market growth. Ports are not only used in oncology but also in patients with autoimmune diseases, chronic pain conditions, or those needing long-term nutrition support via parenteral nutrition. As these treatments become more common, the demand for Huber needles that can safely access these ports without causing complications will continue to grow.

Advancements in needle safety technology are also driving market expansion. With increased awareness of needlestick injuries and the associated health risks, there is a growing emphasis on the development and adoption of safety-engineered Huber needles. These needles reduce the risk of accidental exposure to bloodborne pathogens, protecting both healthcare workers and patients. The focus on improving occupational safety in healthcare settings has led to wider adoption of safety needles, contributing to the overall growth of the Huber needles market.

The aging population is another significant driver of market growth. As the global population ages, the number of individuals living with chronic diseases such as cancer, cardiovascular conditions, and diabetes is increasing. Many of these patients require long-term IV therapies or regular access to vascular ports, driving the demand for Huber needles. Additionally, elderly patients may have more delicate veins, making Huber needles a preferred option for minimizing tissue damage and ensuring comfort during treatments.

Technological advancements in the design and materials used in Huber needles have also contributed to market growth. Innovations that enhance the precision, comfort, and safety of Huber needles have made them more attractive to healthcare providers. The development of smaller gauge needles, more ergonomic designs, and advanced safety features has improved the user experience for both patients and healthcare workers. As these innovations continue, the market for Huber needles is expected to expand further, with healthcare providers seeking the best tools to deliver long-term, high-quality care.

The increasing focus on patient-centered care is another factor influencing the growth of the Huber needles market. As healthcare providers place greater emphasis on improving the quality of life for patients undergoing long-term treatments, there is a growing demand for medical devices that minimize discomfort and complications. Huber needles, with their design focused on reducing pain and protecting vascular ports, align with these goals, making them a critical component in patient care strategies.

With the rising prevalence of chronic diseases, advancements in safety technology, and the growing need for long-term treatment solutions, the Huber needles market is poised for continued growth. As healthcare providers prioritize safety, efficiency, and patient comfort, Huber needles will remain an essential tool in ensuring the safe and effective delivery of critical therapies across various medical disciplines.

Select Competitors (Total 41 Featured) -

  • AngioDynamics, Inc.
  • B. Braun Medical, Inc.
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • EXELINT International Co.
  • Nipro Medical Corporation
  • Smiths Medical
  • Thibaut SAS
  • Vygon SA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Huber Needles - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Oncology and Chronic Disease Management Drives Growth in Huber Needles Market
    • Expansion of Intravenous Drug Administration and Parenteral Nutrition Spurs Adoption of Huber Needles
    • Growth in Use of Huber Needles for Long-term Vascular Access Expands Addressable Market
    • Role of Huber Needles in Enhancing Patient Comfort and Reducing Needle-stick Injuries Strengthens Business Case for Adoption
    • Growth in Use of Huber Needles in Chemotherapy and Blood Transfusions Expands Market Opportunities
    • Role of Huber Needles in Supporting Home-based Infusion Therapy and Parenteral Nutrition Expands Addressable Market
    • Growth in Use of Huber Needles in Central Venous Catheterization and Port Access Strengthens Market Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Huber Needles Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Huber Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Huber Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Huber Needles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for IV Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for IV Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for IV Cancer Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Blood Transfusions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Blood Transfusions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Blood Transfusions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Dialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Lap-Band Adjustments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Lap-Band Adjustments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Lap-Band Adjustments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Home Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Home Parenteral Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Home Parenteral Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Curved Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Curved Display by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Curved Display by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Straight by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Straight by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Straight by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • JAPAN
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • CHINA
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • EUROPE
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Huber Needles by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Huber Needles by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Huber Needles by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • FRANCE
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • GERMANY
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Huber Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Huber Needles by Application - IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Huber Needles by Application - Percentage Breakdown of Value Sales for IV Cancer Treatment, Blood Transfusions, Dialysis, Lap-Band Adjustments, Home Parenteral Nutrition and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Huber Needles by Type - Curved Display and Straight - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Huber Needles by Type - Curved Display and Straight Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for Huber Needles by Type - Percentage Breakdown of Value Sales for Curved Display and Straight for the Years 2014, 2024 & 2030

IV. COMPETITION